These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 623854)
41. Double-blind, controlled trial of inositol treatment of depression. Levine J; Barak Y; Gonzalves M; Szor H; Elizur A; Kofman O; Belmaker RH Am J Psychiatry; 1995 May; 152(5):792-4. PubMed ID: 7726322 [TBL] [Abstract][Full Text] [Related]
42. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Benjamin J; Levine J; Fux M; Aviv A; Levy D; Belmaker RH Am J Psychiatry; 1995 Jul; 152(7):1084-6. PubMed ID: 7793450 [TBL] [Abstract][Full Text] [Related]
43. The human milk component Paquette AF; Carbone BE; Vogel S; Israel E; Maria SD; Patil NP; Sah S; Chowdhury D; Kondratiuk I; Labhart B; Morrow AL; Phillips SC; Kuang C; Hondmann D; Pandey N; Biederer T Proc Natl Acad Sci U S A; 2023 Jul; 120(30):e2221413120. PubMed ID: 37433002 [TBL] [Abstract][Full Text] [Related]
44. Neurobiology and Applications of Inositol in Psychiatry: A Narrative Review. Concerto C; Chiarenza C; Di Francesco A; Natale A; Privitera I; Rodolico A; Trovato A; Aguglia A; Fisicaro F; Pennisi M; Bella R; Petralia A; Signorelli MS; Lanza G Curr Issues Mol Biol; 2023 Feb; 45(2):1762-1778. PubMed ID: 36826058 [TBL] [Abstract][Full Text] [Related]
45. A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5-12. Wozniak J; Farrell A; DiSalvo M; Ceranoglu A; Uchida M; Vaudreuil C; Joshi G; Faraone SV; Cook E; Biederman J Psychopharmacol Bull; 2022 Oct; 52(4):31-51. PubMed ID: 36339275 [TBL] [Abstract][Full Text] [Related]
46. Insulin signaling as a therapeutic mechanism of lithium in bipolar disorder. Campbell IH; Campbell H; Smith DJ Transl Psychiatry; 2022 Aug; 12(1):350. PubMed ID: 36038539 [TBL] [Abstract][Full Text] [Related]
47. Metabolomic profiling relates tianeptine effectiveness with hippocampal GABA, myo-inositol, cholesterol, and fatty acid metabolism restoration in socially isolated rats. Perić I; Lješević M; Beškoski V; Nikolić M; Filipović D Psychopharmacology (Berl); 2022 Sep; 239(9):2955-2974. PubMed ID: 35776189 [TBL] [Abstract][Full Text] [Related]
48. Cardiorenal metabolic biomarkers link early life stress to risk of non-communicable diseases and adverse mental health outcomes. Poplawski J; Radmilovic A; Montina TD; Metz GAS Sci Rep; 2020 Aug; 10(1):13295. PubMed ID: 32764629 [TBL] [Abstract][Full Text] [Related]
49. Chhetri DR Front Pharmacol; 2019; 10():1172. PubMed ID: 31680956 [No Abstract] [Full Text] [Related]
51. Neurometabolic abnormalities in schizophrenia and depression observed with magnetic resonance spectroscopy at 7 T. Taylor R; Osuch EA; Schaefer B; Rajakumar N; Neufeld RW; Théberge J; Williamson PC BJPsych Open; 2017 Jan; 3(1):6-11. PubMed ID: 28243459 [TBL] [Abstract][Full Text] [Related]
52. The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence. Ferrari F; Villa RF Mol Neurobiol; 2017 Sep; 54(7):4847-4865. PubMed ID: 27510505 [TBL] [Abstract][Full Text] [Related]
53. Variations in myo-inositol in fronto-limbic regions and clinical response to electroconvulsive therapy in major depression. Njau S; Joshi SH; Leaver AM; Vasavada M; Van Fleet J; Espinoza R; Narr KL J Psychiatr Res; 2016 Sep; 80():45-51. PubMed ID: 27285661 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia. Chiappelli J; Rowland LM; Wijtenburg SA; Muellerklein F; Tagamets M; McMahon RP; Gaston F; Kochunov P; Hong LE Neuropsychopharmacology; 2015 Aug; 40(9):2157-64. PubMed ID: 25722115 [TBL] [Abstract][Full Text] [Related]
55. Magnetic resonance spectroscopic imaging in the era of pseudoprogression and pseudoresponse in glioblastoma patient management. Shim H; Holder CA; Olson JJ CNS Oncol; 2013 Sep; 2(5):393-6. PubMed ID: 25054660 [No Abstract] [Full Text] [Related]
56. Brain changes in long-term zen meditators using proton magnetic resonance spectroscopy and diffusion tensor imaging: a controlled study. Fayed N; Lopez Del Hoyo Y; Andres E; Serrano-Blanco A; Bellón J; Aguilar K; Cebolla A; Garcia-Campayo J PLoS One; 2013; 8(3):e58476. PubMed ID: 23536796 [TBL] [Abstract][Full Text] [Related]
57. Proton magnetic resonance spectroscopy in depression. Rao NP; Venkatasubramanian G; Gangadhar BN Indian J Psychiatry; 2011 Oct; 53(4):307-11. PubMed ID: 22303038 [TBL] [Abstract][Full Text] [Related]
58. Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. Fayed N; Garcia-Campayo J; Magallón R; Andrés-Bergareche H; Luciano JV; Andres E; Beltrán J Arthritis Res Ther; 2010; 12(4):R134. PubMed ID: 20609227 [TBL] [Abstract][Full Text] [Related]
59. Perinatal n-3 fatty acid deficiency selectively reduces myo-inositol levels in the adult rat PFC: an in vivo (1)H-MRS study. McNamara RK; Able J; Jandacek R; Rider T; Tso P; Lindquist DM J Lipid Res; 2009 Mar; 50(3):405-411. PubMed ID: 18802197 [TBL] [Abstract][Full Text] [Related]
60. Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain. Tyeryar KR; Vongtau HO; Undieh AS BMC Neurosci; 2008 Jan; 9():12. PubMed ID: 18218113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]